151 related articles for article (PubMed ID: 37345554)
21. Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats.
Huang H; Jiang Y; Mao G; Yuan F; Zheng H; Ruan Y; Wu T
J Sci Food Agric; 2017 Mar; 97(4):1359-1366. PubMed ID: 27363537
[TBL] [Abstract][Full Text] [Related]
22. Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells.
Kim SI; Han DC; Lee HB
J Am Soc Nephrol; 2000 Jan; 11(1):80-87. PubMed ID: 10616843
[TBL] [Abstract][Full Text] [Related]
23. Renoprotective effects of berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats.
Ni WJ; Ding HH; Zhou H; Qiu YY; Tang LQ
Eur J Pharmacol; 2015 Oct; 764():448-456. PubMed ID: 26192633
[TBL] [Abstract][Full Text] [Related]
24. Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats.
Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Harima M; Suzuki K; Kawachi H; Watanabe K
J Nutr Biochem; 2013 May; 24(5):796-802. PubMed ID: 22898567
[TBL] [Abstract][Full Text] [Related]
25. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats.
Qi MY; Kai-Chen ; Liu HR; Su YH; Yu SQ
J Ethnopharmacol; 2011 Dec; 138(3):731-6. PubMed ID: 22027446
[TBL] [Abstract][Full Text] [Related]
26. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
[TBL] [Abstract][Full Text] [Related]
27. Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis.
Su K; Yi B; Yao BQ; Xia T; Yang YF; Zhang ZH; Chen C
Pharmacol Res; 2020 Jun; 156():104778. PubMed ID: 32247822
[TBL] [Abstract][Full Text] [Related]
28. Beneficial effects of C-peptide on renal morphology in diabetic rats.
Sun W; Gao X; Zhao X; Cui D; Xia Q
Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):893-9. PubMed ID: 21106770
[TBL] [Abstract][Full Text] [Related]
29. Enhanced expression of group IIA secreted phospholipase A2 by elevated glucose levels in cytokine-stimulated rat mesangial cells and in kidneys of diabetic rats.
Vlachojannis GJ; Scholz-Pedretti K; Fierlbeck W; Geiger H; Pfeilschifter J; Kaszkin M
Clin Nephrol; 2005 May; 63(5):356-67. PubMed ID: 15909595
[TBL] [Abstract][Full Text] [Related]
30. Liraglutide protects from renal damage via Akt-mTOR pathway in rats with diabetic kidney disease.
Liao TT; Zhao LB; Liu H; He RL; Wang YQ; Li J
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):117-125. PubMed ID: 31389583
[TBL] [Abstract][Full Text] [Related]
31. Amygdalin alleviates renal injury by suppressing inflammation, oxidative stress and fibrosis in streptozotocin-induced diabetic rats.
Chen J; Hu Y; Mou X; Wang H; Xie Z
Life Sci; 2021 Jan; 265():118835. PubMed ID: 33253723
[TBL] [Abstract][Full Text] [Related]
32. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome.
Ding T; Wang S; Zhang X; Zai W; Fan J; Chen W; Bian Q; Luan J; Shen Y; Zhang Y; Ju D; Mei X
Phytomedicine; 2018 Mar; 41():45-53. PubMed ID: 29519318
[TBL] [Abstract][Full Text] [Related]
33. Extracts of Bauhinia championii (Benth.) Benth. inhibit NF-B-signaling in a rat model of collagen-induced arthritis and primary synovial cells.
Xu W; Huang M; Zhang Y; Li H; Zheng H; Yu L; Chu K
J Ethnopharmacol; 2016 Jun; 185():140-6. PubMed ID: 26988564
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of diabetic nephropathy by Sanziguben Granule inhibiting EMT through Nrf2-mediated anti-oxidative effects in streptozotocin (STZ)-induced diabetic rats.
Zhang C; Li Q; Lai S; Yang L; Shi G; Wang Q; Luo Z; Zhao R; Yu Y
J Ethnopharmacol; 2017 Jun; 205():207-216. PubMed ID: 28501426
[TBL] [Abstract][Full Text] [Related]
35. H
Li Y; Li L; Zeng O; Liu JM; Yang J
Ren Fail; 2017 Nov; 39(1):265-272. PubMed ID: 27882817
[TBL] [Abstract][Full Text] [Related]
36. Liraglutide suppresses production of extracellular matrix proteins and ameliorates renal injury of diabetic nephropathy by enhancing Wnt/β-catenin signaling.
Huang L; Lin T; Shi M; Chen X; Wu P
Am J Physiol Renal Physiol; 2020 Sep; 319(3):F458-F468. PubMed ID: 32715762
[TBL] [Abstract][Full Text] [Related]
37. PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.
Zakaria EM; El-Maraghy NN; Ahmed AF; Ali AA; El-Bassossy HM
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):621-631. PubMed ID: 28224182
[TBL] [Abstract][Full Text] [Related]
38. A novel formula from mulberry leaf ameliorates diabetic nephropathy in rats via inhibiting the TGF-β1 pathway.
Zhang Q; Lu Y; Ma Z; Li Y; Guo J; Meng Q; Bian H
Food Funct; 2015 Oct; 6(10):3307-15. PubMed ID: 26242486
[TBL] [Abstract][Full Text] [Related]
39. Fucoxanthin regulates Nrf2 signaling to decrease oxidative stress and improves renal fibrosis depending on Sirt1 in HG-induced GMCs and STZ-induced diabetic rats.
Yang G; Li Q; Peng J; Jin L; Zhu X; Zheng D; Zhang Y; Wang R; Song Y; Hu W; Xie X
Eur J Pharmacol; 2021 Dec; 913():174629. PubMed ID: 34780751
[TBL] [Abstract][Full Text] [Related]
40. Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K/AKT pathway.
Nie Y; Fu C; Zhang H; Zhang M; Xie H; Tong X; Li Y; Hou Z; Fan X; Yan M
BMC Complement Med Ther; 2020 Oct; 20(1):321. PubMed ID: 33097050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
